Skip to main content
Andon Health Co.,Ltd. logo

Andon Health Co.,Ltd. — Investor Relations & Filings

Ticker · 002432 ISIN · CNE100000Q84 Shenzhen Stock Exchange Manufacturing
Open in API
Filings indexed 1,984 across all filing types
Latest filing 2026-05-26 Notice of Dividend Amou…
Country CN China
Listing Shenzhen Stock Exchange 002432

About Andon Health Co.,Ltd.

https://www.jiuan.com

Andon Health Co., Ltd. specializes in the research, development, and manufacturing of electronic healthcare products and cloud-based health management solutions. The company’s core portfolio includes digital blood pressure monitors, blood glucose meters, pulse oximeters, infrared thermometers, and smart body scales. Through its subsidiary iHealth Labs, the company integrates medical hardware with mobile internet technologies, enabling users to track and manage personal health data via smartphone applications. Andon Health provides comprehensive digital health ecosystems, focusing on chronic disease management and remote patient monitoring. The company also produces diagnostic kits, including rapid antigen tests. Its operations emphasize the convergence of traditional medical devices with Internet of Things (IoT) connectivity to improve healthcare accessibility and data-driven wellness management.

Recent filings

Filing Released Lang Actions
2025年年度权益分派实施公告
Notice of Dividend Amount Classification · 86% confidence The document is a detailed implementation announcement of the company’s 2025 annual profit distribution (dividend) plan, specifying cash dividend per share, record date, ex-dividend date, payment date, recipients, and related calculation methods. These characteristics align exactly with a Notice of Dividend Amount, not an earnings release or financial report. Therefore, the appropriate classification is DIV.
2026-05-26 Chinese
2025年年度股东会决议公告
Declaration of Voting Results & Voting Rights Announcements Classification · 90% confidence The document is an official announcement of the resolutions and detailed voting results from the company’s 2025 Annual General Meeting of shareholders (including vote counts for each proposal and legal opinions). This fits the definition of Declaration of Voting Results & Voting Rights Announcements (DVA).
2026-05-21 Chinese
关于与专业投资机构共同投资的进展公告
Capital/Financing Update Classification · 95% confidence The document is an official announcement by Tianjin Jiuan Medical Electronics Co., Ltd. detailing the progress of its co-investment with professional investment institutions into a private equity fund, including changes to the fund’s name, general partner, term, partnership agreement and investment structure. This is a financing activity update rather than a full financial report, share issuance notice, or management change. It clearly falls under Capital/Financing Update.
2026-05-18 Chinese
关于2021年股票期权激励计划第四个行权期采用自主行权模式的提示性公告
Share Issue/Capital Change Classification · 82% confidence The document is a detailed corporate announcement regarding the company’s 2021 stock option incentive plan and the fourth exercise period, including exercise conditions, share quantities, exercise price and issuance arrangements. It is not a financial report (10-K, IR, ER), nor an AGM presentation, call transcript, management change or dividend notice. Instead, it informs investors of a forthcoming share‐issuance event under the equity incentive plan and related capital impact. Therefore it best fits the "Share Issue/Capital Change" category.
2026-05-11 Chinese
关于与专业投资机构共同投资的进展公告
Capital/Financing Update Classification · 95% confidence The document is an announcement from Tianjin Jiua Medical Electronics Co., Ltd. regarding the progress of an investment with a professional investment institution. It details the company's participation as a limited partner in a fund and the completion of fundraising by the general partner. The document is short (639 characters) and focuses on providing an update about investment progress rather than presenting financial statements or detailed financial data. It does not contain financial results, audit information, or regulatory certifications. This fits the category of a Capital/Financing Update (CAP), which covers updates on company fundraising and financing activities.
2025-12-30 Chinese
2025年第四次临时股东大会法律意见书
Declaration of Voting Results & Voting Rights Announcements Classification · 95% confidence The document is a legal opinion letter issued by a law firm regarding the convening, procedures, attendance qualifications, agenda, and voting results of the 2025 fourth extraordinary general meeting of shareholders of Tianjin Jiua Medical Electronics Co., Ltd. It details the legal compliance of the meeting process and the validity of the resolutions passed. The document includes detailed voting results on various proposals including changes in registered capital, board elections, and amendments to company rules. This is not a full annual or interim report, nor an earnings release or management discussion. It is not a proxy solicitation or a director dealing report. It is a legal opinion related to a shareholders meeting and the voting results. According to the filing definitions, the closest match is "Declaration of Voting Results & Voting Rights Announcements (DVA)" because it officially reports the voting results of a shareholders meeting. The document length is over 8000 characters and contains detailed voting results, so it is not a mere announcement or report publication announcement. Therefore, the correct classification is DVA with high confidence.
2025-12-15 Chinese

Browse filings by year

17 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.